Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


FOOT AMPUTATION side effect

What is FOOT AMPUTATION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   FOOT AMPUTATION and Recently Reported Side Effects   FOOT AMPUTATION and 15 most Active Side Effect polls   FOOT AMPUTATION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with FOOT AMPUTATION

ALEVE  FABRAZYME  HUMULIN  LANTUS  LETROZOLE  MOXIFLOXACIN  NATALIZUMAB  NOREPINEPHRINE  OMNISCAN  RENAGEL  RITUXIMAB  SUTENT  TAMOXIFEN  TEVETEN  THYMOGLOBULIN  TYSABRI  


Humulin Side Effects Report #5620351-2
Consumer or non-health professional from TURKEY reported HUMULIN problem on Jan 28, 2008. Female patient, weighting 176.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with HUMULIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, toe amputation, . HUMULIN dosage: unknown. During the same period patient was treated with LANTUS. Patient recovered.

Moxifloxacin Side Effects Report #5486700-3
MOXIFLOXACIN problem was reported by a Physician from SOUTH AFRICA on Oct 12, 2007. Male patient, 72 years of age, weighting 145.5 lb, was diagnosed with skin infection, medical diet, anaesthesia, hypotonia and was treated with MOXIFLOXACIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, leg amputation, wound debridement, . MOXIFLOXACIN dosage: unknown. During the same period patient was treated with VITAMIN CAP, ASCORBIC ACID, THIAMINE, DIPRIVAN, PROSTIGMIN BROMIDE, ROBINUL, TACRIUM. Patient was hospitalized and became disabled. Patient recovered.

Natalizumab Side Effects Report #5450887-9
Health Professional from UNITED STATES reported NATALIZUMAB problem on Sept 04, 2007. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: foot amputation, limb injury, road traffic accident, . NATALIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.

Renagel Side Effects Report #5410275-8
RENAGEL problem was reported by a Health Professional from UNITED STATES on July 25, 2007. Male patient, 48 years of age, weighting 163.1 lb, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: foot amputation, gangrene, hypocalcaemia, . RENAGEL dosage: unknown. During the same period patient was treated with EPOGEN, VENOFER, TOPAMAX, WARFARIN, ASCORBIC ACID, CALCIUM WITH VITAMIN D. Patient was hospitalized and became disabled. Patient recovered.


Rituximab Side Effects Report #5418976-2
Physician from GERMANY reported RITUXIMAB problem on Aug 14, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: foot amputation, localised infection, multi-organ failure, staphylococcal sepsis, . RITUXIMAB dosage: unknown. During the same period patient was treated with REMICADE, METHOTREXATE, LEFLUNOMIDE, METYSOLON, VOLTAREN, MOBIC, RAMIPRIL, CALCIUM D. Patient was hospitalized. Patient died on 04/21/2007.

Teveten Side Effects Report #5391725-2
TEVETEN problem was reported by a Health Professional from UNITED STATES on July 03, 2007. Male patient, 77 years of age, was diagnosed with hypertension and was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: foot amputation, . TEVETEN dosage: 600 MG QD PO. During the same period patient was treated with ATENOLOL, GLICLAZIDE, METFORMIN. Patient was hospitalized. Patient recovered.

Thymoglobulin Side Effects Report #5423728-3
Consumer or non-health professional from UNITED STATES reported THYMOGLOBULIN problem on May 25, 2004. Male patient, 53 years of age, weighting 180.3 lb, was diagnosed with renal transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, leg amputation, vascular insufficiency, . THYMOGLOBULIN dosage: 125 MG QD. During the same period patient was treated with ASPIRIN, CELLCEPT, INSULIN, ACYCLOVIR, ALLOPURINOL, CELEXA, PLAVIX, SENOKOT. Patient was hospitalized. Patient recovered.

Teveten Side Effects Report #5391725-2
TEVETEN problem was reported by a Health Professional from UNITED STATES on July 03, 2007. Male patient, 77 years of age, was diagnosed with hypertension and was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: foot amputation, . TEVETEN dosage: 600 MG QD PO. During the same period patient was treated with ATENOLOL, GLICLAZIDE, METFORMIN. Patient was hospitalized. Patient recovered.

Thymoglobulin Side Effects Report #5423728-3
Consumer or non-health professional from UNITED STATES reported THYMOGLOBULIN problem on May 25, 2004. Male patient, 53 years of age, weighting 180.3 lb, was diagnosed with renal transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, leg amputation, vascular insufficiency, . THYMOGLOBULIN dosage: 125 MG QD. During the same period patient was treated with ASPIRIN, CELLCEPT, INSULIN, ACYCLOVIR, ALLOPURINOL, CELEXA, PLAVIX, SENOKOT. Patient was hospitalized. Patient recovered.


Renagel Side Effects Report #5362844-1
RENAGEL problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Male patient, 48 years of age, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: foot amputation, . RENAGEL dosage: unknown. Patient was hospitalized. Patient recovered.

Omniscan Side Effects Report #5259322-7
Consumer or non-health professional from SINGAPORE reported OMNISCAN problem on Feb 20, 2007. Male patient, 66 years of age, was diagnosed with ischaemia and was treated with OMNISCAN. After drug was administered, patient experienced the following problems/side effects: foot amputation, gangrene, haemodialysis, leg amputation, nephrogenic fibrosing dermopathy, pneumonia, sepsis, . OMNISCAN dosage: unknown. During the same period patient was treated with ASPIRIN, BISOPROLOL FUMARATE, FAMOTIDINE, FENOFIBRATE, FERROUS FUMARATE, METOCLOPRAMIDE. Patient recovered.

Sutent Side Effects Report #5596494-9
SUTENT problem was reported by a Physician from GERMANY on Jan 09, 2008. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: cutis laxa, foot amputation, . SUTENT dosage: DAILY DOSE:50MG. Patient was hospitalized. Patient recovered.

Norepinephrine Side Effects Report #5489552-0
Pharmacist from UNITED STATES reported NOREPINEPHRINE BITARTRATE problem on Oct 16, 2007. Female patient, 54 years of age, weighting 191.6 lb, was diagnosed with hypotension, septic shock and was treated with NOREPINEPHRINE BITARTRATE. After drug was administered, patient experienced the following problems/side effects: dry gangrene, foot amputation, peripheral ischaemia, . NOREPINEPHRINE BITARTRATE dosage: unknown. During the same period patient was treated with NOREPINEPHRINE BITARTRATE, VASOPRESSIN, AZITHROMYCIN, CEFTRIAXONE, CEFTAZIDIME, CLINDAMYCIN, TOBRAMYCIN. Patient recovered.

Fabrazyme Side Effects Report #5467038-7
FABRAZYME problem was reported by a Physician from UNITED STATES on Sept 24, 2007. Male patient, 34 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, foot amputation, . FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with TORSEMIDE, PROGRAF, PREDNISONE, COLACE, CALCITRIOL, ZOLOFT. Patient was hospitalized and became disabled. Patient recovered.


Tysabri Side Effects Report #5762952-7
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on May 28, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, foot amputation, gangrene, localised infection, opportunistic infection, progressive multiple sclerosis, sepsis, . TYSABRI dosage: unknown. Patient died on 03/27/2008.

Letrozole Side Effects Report #5535167-5
LETROZOLE VS TAMOXIFEN problem was reported by a Physician from DENMARK on Nov 29, 2007. Female patient, 61 years of age, weighting 162.0 lb, was diagnosed with breast cancer and was treated with LETROZOLE VS TAMOXIFEN. After drug was administered, patient experienced the following problems/side effects: arterial stenosis limb, arteriosclerosis, foot amputation, intermittent claudication, peripheral arterial occlusive disease, . LETROZOLE VS TAMOXIFEN dosage: 2.5 MG, QD. Patient was hospitalized and became disabled. Patient recovered.

Letrozole Side Effects Report #5513765-2
Physician from DENMARK reported LETROZOLE problem on Nov 02, 2007. Female patient, 61 years of age, weighting 162.0 lb, was diagnosed with breast cancer and was treated with LETROZOLE. After drug was administered, patient experienced the following problems/side effects: arterial stenosis limb, arteriosclerosis, foot amputation, intermittent claudication, peripheral arterial occlusive disease, . LETROZOLE dosage: 2.5 MG, QD. Patient was hospitalized and became disabled. Patient recovered.

Letrozole Side Effects Report #5523072-X
LETROZOLE VS TAMOXIFEN problem was reported by a Physician from DENMARK on Nov 13, 2007. Female patient, 61 years of age, weighting 162.0 lb, was diagnosed with breast cancer and was treated with LETROZOLE VS TAMOXIFEN. After drug was administered, patient experienced the following problems/side effects: arterial stenosis limb, arteriosclerosis, foot amputation, intermittent claudication, peripheral arterial occlusive disease, . LETROZOLE VS TAMOXIFEN dosage: 2.5 MG, QD. Patient was hospitalized and became disabled. Patient recovered.

Lantus Side Effects Report #5450039-2
Health Professional from INDIA reported LANTUS problem on Sept 07, 2007. Female patient, 56 years of age, weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: diabetic foot, fall, foot amputation, gangrene, hypoglycaemia, impaired healing, limb injury, sepsis, toe amputation, . LANTUS dosage: unknown. During the same period patient was treated with LISPRO, METFORMIN, HUMALOG. Patient was hospitalized. Patient recovered.


Aleve Side Effects Report #5430471-3
ALEVE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2007. Female patient, 54 years of age, weighting 110.2 lb, was diagnosed with nerve compression and was treated with ALEVE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal pain upper, foot amputation, gastric perforation, gastric ulcer, gastric ulcer surgery, skin discolouration, toe amputation, unevaluable event, . ALEVE dosage: UNIT DOSE: 220 MG. Patient was hospitalized and became disabled. Patient recovered.

Tamoxifen Side Effects Report #5300442-6
Consumer or non-health professional from UNITED STATES reported TAMOXIFEN CITRATE problem on Apr 13, 2007. Female patient, weighting 120.0 lb, was diagnosed with breast cancer and was treated with TAMOXIFEN CITRATE. After drug was administered, patient experienced the following problems/side effects: amputation, foot amputation, gangrene, sepsis, thrombosis, . TAMOXIFEN CITRATE dosage: 20MG QD PO. Patient was hospitalized and became disabled. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about FOOT AMPUTATION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about FOOT AMPUTATION